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Abstract
Neighborhoods with high poverty rates have limited resources to support residents’ health. Using census data, we calculated 
the proportion of each Women’s Interagency HIV Study participant’s census tract (neighborhood) living below the poverty 
line. We assessed associations between neighborhood poverty and (1) unsuppressed viral load [VL] in HIV-seropositive 
women, (2) uncontrolled blood pressure among HIV-seropositive and HIV-seronegative hypertensive women, and (3) uncon-
trolled diabetes among HIV-seropositive and HIV-seronegative diabetic women using modified Poisson regression models. 
Neighborhood poverty was associated with unsuppressed VL in HIV-seropositive women (> 40% versus ≤ 20% poverty 
adjusted prevalence ratio (PR), 1.42; 95% confidence interval (CI) 1.04–1.92). In HIV-seronegative diabetic women, moder-
ate neighborhood poverty was associated with uncontrolled diabetes (20–40% versus ≤ 20% poverty adjusted PR, 1.75; 95% 
CI 1.02–2.98). Neighborhood poverty was associated with neither uncontrolled diabetes among HIV-seropositive diabetic 
women, nor uncontrolled hypertension in hypertensive women, regardless of HIV status. Women living in areas with con-
centrated poverty may need additional resources to control health conditions effectively.
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Introduction
Effective management of HIV and other chronic ill-
nesses such as diabetes and hypertension requires con-
sistent access and adherence to medications and adequate 
healthcare. Uncontrolled HIV, hypertension, and diabetes 
escalate healthcare costs and increase morbidity and mor-
tality [1–3]. Unsuppressed HIV infection also increases 
risk of HIV transmission [4–6]. Approximately 73% of 
people diagnosed with HIV in the United States (US) 
received HIV care in 2014, but only 58% had ≥ 1 unde-
tectable plasma viral load (VL) measurement [7] and 48% 
achieved sustained viral suppression that year [8]. Viral 
suppression is lowest in minority populations [7, 8]. In 
the US, approximately 52% of individuals with hyperten-
sion in 2015–2016 and 52% of individuals with diabetes 
during 2009–2012 had poorly controlled disease [9, 10]. 
The reasons for poor control of HIV, hypertension, and 
diabetes likely include both individual- and community-
level factors.
Over half of the 15% of Americans living below the 
poverty line live near one another in concentrated areas 
of poverty [11, 12]. Since 2000, the number of people liv-
ing in areas with a poverty rate ≥ 20% increased by 56%, 
with approximately a quarter of the US population living 
in these areas [13, 14]. Resources that support the health 
and well-being of the population overall, such as access 
to healthcare, stores selling healthy food, and recreational 
facilities are often limited in places with high poverty rates 
[15, 16]. Several studies have documented the associations 
of neighborhood-level poverty, independent of individual 
socioeconomic status, with morbidity and mortality due 
to HIV [17–19] and other diseases including heart disease 
[15, 20] and diabetes [21]. Compared to white Americans, 
more minorities live in neighborhoods with high propor-
tions of poor residents, a differential that likely promotes 
pervasive racial disparities in health [12, 16, 21–24].
Despite evidence that contextual and structural inequi-
ties impact disease prevalence [15, 17–21], their effects on 
critical markers of HIV control (e.g., virologic suppres-
sion) and primary care (e.g., blood pressure or glucose 
control) have received relatively little attention [15, 25, 
26]. In our conceptual model, neighborhood-level poverty 
worsens people’s health and their ability to control disease, 
through deprivation of important resources such as health 
care, education, economic opportunities, and affordable 
food and housing [15, 16, 27, 28]. The absence of these 
resources may increase stress levels and ultimately inter-
fere with a person’s ability to adhere to treatment regimens 
and adequately control their disease [29]. The Women’s 
Interagency HIV Study (WIHS) follows women with or 
at risk for HIV, many of whom live in poverty [30–32] 
and experience other comorbid conditions [33–35]. In the 
WIHS, US Census data are linked to residential addresses 
of consenting women, providing an opportunity to char-
acterize neighborhood-level poverty in populations with 
high prevalence of diseases that are manageable with 
appropriate treatment and care. The primary aims of this 
analysis were to examine prevalence of controlled HIV, 
hypertension, and diabetes, and to assess the relationships 
between neighborhood-level poverty and control of these 
conditions among a representative group of US women 
with or at risk for HIV infection.
Methods
Study Population
The WIHS is a multicenter prospective cohort study estab-
lished in 1993 to investigate clinical and epidemiologic 
aspects of HIV infection among women. Participants were 
recruited during four waves (1994–1995, 2001–2002, 
2011–2012, and 2013–2015) from ten centers. The original 
sites (Brooklyn, NY; Bronx, NY; Washington, DC; Chicago, 
IL; Los Angeles, CA; San Francisco, CA) enrolled women 
during the first three recruitment waves, and the southern 
sites (Chapel Hill, NC; Atlanta, GA; Miami, FL; Birming-
ham, AL/Jackson, MS) enrolled participants in the most 
recent wave. Study visits occur at 6-month intervals and con-
sist of standardized interviews, clinical exams, and specimen 
collection. Detailed descriptions of recruitment, retention, 
and characteristics of WIHS participants have been previ-
ously published [30–32]. Each site used ArcGIS version 10.2 
(Environmental Systems Research Institute, Redlands, CA) 
to geocode the current addresses of participants who con-
sented to this procedure and attended a study visit between 
1 April and 30 September 2015 (henceforth the index visit). 
Federal Information Processing Standard (FIPS) codes for 
state, county, census tract, and census block group were 
assigned to each participant based on geocoded coordinates.
We included participants in this analysis if they attended 
the index visit and were assigned a valid FIPS code for their 
current address (no participants from the Los Angeles site 
attended the index visit). Study protocols were approved by 
Institutional Review Boards (IRBs) at each clinical site, and 
specifically for this analysis, were reviewed by the Univer-
sity of North Carolina at Chapel Hill IRB. Written informed 
consent was obtained from all participants.
Contextual Data
The American Community Survey (ACS) is a household 
survey administered by the US Census Bureau that samples 
3 million addresses yearly to obtain timely demographic, 
economic, and housing information from residents [36]. 
ACS variables are reported in 1-, 3- and 5-year estimates, 
depending on population size (only 5-year estimates are 
reported for geographic units with small populations) and 
sensitivity of the particular variable.
In this analysis, we used census tract as a proxy for a 
person’s neighborhood [37]. Five-year ACS poverty esti-
mates (2010–2014) for census tracts [38] were linked to 
WIHS participant census tracts using FIPS codes. Census 
tract-level (henceforth neighborhood) poverty was defined 
as the proportion of each participant’s census tract living 
below the federal poverty line during the past 12 months. 
Five-year estimates of the percentage of the population 
living below the poverty line are available at the census 
tract-level, but not the census block-group level. The US 
Census defines a poverty area as census tracts where at 
least 20% of the population lives below the poverty line 
[14]. We classified neighborhood poverty into three cat-
egories: ≤ 20%, > 20–40%, or > 40–100% of the total popu-
lation living below the poverty line. These categorizations 
have previously been used to classify areas with low, high, 
and extreme poverty, respectively [14, 39]. We varied the 
cut-points in sensitivity analyses to assess if changes in 
the functional form of the exposure impacted the observed 
associations.
Health Outcomes
We used WIHS interview, physical examination, and 
laboratory data to classify all health outcomes. For HIV-
seropositive women, we classified unsuppressed HIV 
as > 200 copies/mL. We defined a hypertension diagnosis 
(in both HIV-seropositive and -seronegative women) as 
self-reported hypertension [40] and/or self-reported use of 
anti-hypertensive medications [41] at or before the index 
visit to ensure that hypertensive women were aware of 
their diagnosis. Although anti-hypertensive medication 
can be prescribed for conditions unrelated to hyperten-
sion, we assumed this to be minimal among participants. 
For women with a diagnosis of hypertension, we defined 
uncontrolled hypertension as systolic blood pressure > 140 
(mm Hg) or diastolic blood pressure > 90 at the index visit.
For all women (HIV-seropositive and -seronegative), 
we defined a diagnosis of diabetes as ever self-reporting 
anti-diabetic medication or, when non-pregnant, (1) ever 
having two fasting serum glucose measurements ≥ 126 mg/
dL, or (2) measurements of HgbA1c ≥ 6.5% and fasting 
serum glucose ≥ 126 mg/dL. Among women who were 
classified as ever having been diagnosed with diabetes, 
we classified uncontrolled diabetes at the index visit as an 
HgbA1c measurement > 7.0% [9].
Covariates
Self-reported race/ethnicity (African American non-His-
panic, white non-Hispanic, Hispanic, or other), and birthdate 
were recorded at entry into the WIHS cohort. Annual house-
hold income (≤ $12,000, $12,001–$30,000, or > $30,000 
per year), current insurance status [uninsured or insured 
(privately, publicly, or unknown type)], receipt of food 
stamps, including Temporary Assistance to Needy Families 
program and the Supplemental Nutrition Assistance Pro-
gram (received or not received), marital status (married, 
cohabitating, widowed/divorced/separated, never married, 
or other), education status (< grade 12, grade 12, or > grade 
12), body mass index, and self-reported receipt of health-
care from a provider in the preceding 6 months (received 
or not received) were collected for all women at the index 
visit. Self-reported AIDS diagnosis prior to the index visit; 
and enrollment status in the AIDS Drug Assistance Program 
(ADAP) (enrolled or not enrolled), CD4 cell count, HIV 
VL, and antiretroviral therapy (ART) status (defined as self-
reported use of ≥ 3 antiretroviral medications, one of which 
is a protease inhibitor, a non-nucleoside reverse transcriptase 
inhibitor, one of the nucleoside reverse transcriptase inhibi-
tors abacavir or tenofovir, an integrase inhibitor, or an entry 
inhibitor) at the index visit were also collected for HIV-
seropositive women.
Statistical Analysis
We evaluated three outcomes: unsuppressed VL among 
HIV-seropositive participants, uncontrolled diabetes among 
diabetic participants, and uncontrolled hypertension among 
hypertensive participants. HIV viral suppression, diabetes 
control, and hypertension control were analyzed separately 
with the latter two stratified by HIV status, for a total of 
five models. Modified Poisson regression models [42] using 
generalized estimating equations (GEE) were fit to estimate 
prevalence ratios (PRs) and robust 95% confidence intervals 
(CIs) for each outcome. We used GEE with an independent 
working covariance matrix to account for clustering due to 
residents living in the same census tract.
Based on a review of the literature and construction 
of causal diagrams [43], viral suppression models were 
adjusted for race/ethnicity, self-reported AIDS diagno-
sis prior to the index visit, age at index visit (continu-
ous), income category, combined health insurance/ADAP 
enrollment status (uninsured/no ADAP; uninsured/ADAP; 
insured/no ADAP; insured/ADAP), and CD4 cell count 
(continuous). The models for both diabetes and hyperten-
sion control were adjusted for race, age at index visit (con-
tinuous), income and either health insurance status (HIV-
seronegative women) or combined health insurance/ADAP 
enrollment status (HIV-seropositive women). The diabetes 
control model was adjusted for receipt of food stamps; 
previously, this program has been associated with glucose 
control because it provides recipients with access to basic 
foods, enabling participants to purchase healthier and often 
more expensive items (e.g., medication). [44, 45]. We did 
not include self-reported AIDS diagnosis prior to the index 
visit, CD4 cell count, or HIV VL in the final diabetes and 
hypertension models for HIV-seropositive women because 
addition of these variables did not alter the effect estimates. 
We conducted all statistical analyses in SAS version 9.4 
(SAS Institute Inc., Cary, NC).
Results
In total, 2342 women attended the index visit; 2094 women 
(89%) provided a residential address that could be geocoded 
and were included in this analysis. Among excluded women, 
169 (68%) refused to provide their address, 29 (12%) did 
not have a stable address, 24 (10%) provided an address 
that could not be matched to a location in ArcGIS, and 26 
(11%) were missing an address. Most geocoded participants 
were African American, non-Hispanic (N = 1519, 73%) 
and most were unmarried (N = 1680, 80%). Nearly half of 
women reported an annual household income ≤ $12,000 
(N = 1024, 49%), 32% (N = 678) had less than a high school 
education, 25% (N = 517) reported either injection or non-
injection drug use in the past 6 months, and 58% received 
food stamps (N = 1218). The median age of participants was 
49 years (interquartile range (IQR), 42–55) [Table 1]. Com-
pared to geocoded participants, non-geocoded participants 
were less likely to have diabetes and hypertension, and were 
more likely to have HIV infection and missing income and 
drug use information [Supplemental Table 1]. The remaining 
analyses only consider geocoded women.
Most geocoded women were HIV-seropositive (N = 1463, 
70%), of whom 1271 (87%) were receiving ART. In total, 
233 HIV-seropositive women (16%) had a VL > 200 copies/
mL; 120 of these women reported current receipt of ART. 
Overall, 1188 women (57%) had a hypertension diagnosis 
(848 HIV-seropositive, 340 HIV-seronegative); 27 women 
were classified as hypertensive based solely on report of 
anti-hypertensive medication. Of 1188 hypertensive women, 
803 (68%) had controlled hypertension at the index visit: 
601 HIV-seropositive (71%) and 202 HIV-seronegative 
(59%). A total of 418 women (20%) had been diagnosed with 
diabetes (280 HIV-seropositive, 138 HIV-seronegative), of 
whom 231 (55%) had controlled diabetes: 161 HIV-seropos-
itive (58%) and 70 HIV-seronegative (51%) [Table 2]. The 
proportions of diabetic women with controlled diabetes who 
were receiving food stamps were approximately equivalent 
in HIV-seropositive and -seronegative women (68% versus 
66%). However, a smaller proportion of HIV-seropositive 
women with uncontrolled diabetes received food stamps 
(60%, versus 69% of HIV-seronegative women).
Only 322 (15%) women had not seen a medical pro-
vider in the last 6 months [9% (N = 138) of HIV-seropos-
itive women; 12% (N = 157) of hypertensive women; 12% 
(N = 52) of diabetic women]. Among women who had not 
seen a medical provider, 35 (25%) were HIV-seropositive 
with an unsuppressed VL, 42 (27%) were diagnosed with 
hypertension and had uncontrolled hypertension, and 12 
(23%) were diagnosed with diabetes and had uncontrolled 
diabetes.
Participants lived in census tracts where the median pro-
portion of the population living below the poverty line was 
26% (IQR, 16–37%). The median proportion of a respond-
ent’s own race living below the poverty line in their cen-
sus tract was substantially higher among African Ameri-
can, non-Hispanics (30%; IQR, 19–42%) and participants 
of other (non-white) races/ethnicities (23%; IQR, 11–39%) 
than white participants (17%; IQR, 9–27%). The median 
proportion of people living in poverty in the participant’s 
census tract decreased as the respondent’s household income 
increased (≤ $12,000, median, 29%; $12,001–$30,000, 
median, 26%; > $30,000, median, 18%). The median pro-
portion of the census tract population living below the pov-
erty line was 12% (IQR, 8–17%) for participants residing 
in the ≤ 20% neighborhood poverty category, 29% (IQR, 
25–34%) for participants residing in the > 20–40% neigh-
borhood poverty category, and 47% (IQR, 43–50%) for par-
ticipants residing in the > 40–100% neighborhood poverty 
category [Table 3].
Viral Suppression
Although most HIV-seropositive women were receiving 
ART, the proportion decreased as neighborhood poverty 
increased [≤ 20% poverty: N = 460/514 (89%); > 20–40% 
poverty: N = 575/657 (88%); > 40–100% poverty: 
N = 236/292 (81%); p = 0.002]. Among 192 HIV-seroposi-
tive women not receiving ART, most had seen a healthcare 
provider in the previous 6 months; although similar across 
poverty levels, the proportion was highest in women liv-
ing in areas of extreme poverty [≤ 20% poverty: N = 42/54 
(78%); > 20–40% poverty: N = 65/82 (79%); > 40–100% pov-
erty: N = 50/56 (89%); p = 0.2]. The prevalence of unsup-
pressed VL was higher among HIV-seropositive women 
living in neighborhoods of extreme poverty in both unad-
justed analyses (> 40–100% versus ≤ 20% PR, 1.79; CI, 
1.30–2.48) and analyses adjusted for individual-level mark-
ers of HIV disease, socioeconomic status, and demograph-
ics (> 40–100% versus ≤ 20% adjusted PR [aPR], 1.42; CI, 
1.04–1.92). The relationship between unsuppressed VL and 
poverty was attenuated and less precise among women liv-
ing in neighborhoods of moderate poverty in unadjusted 
Table 1  Demographic characteristics of 2094 participants with geocoded addresses, Women’s Interagency HIV Study, 2015
Median IQR
Age 49.3 (41.9–55.4)
Body mass index 30.8 (25.8–37.2)
N %
Race/ethnicity
 African American, non-Hispanic 1519 73
 White, non-Hispanic 191 9
 Hispanic 312 15









 < Grade 12 678 32
 Grade 12 641 31
> Grade 12 723 35
Missing 52 3
Residence type
 Own house/apartment 1701 81
 Parent’s house 74 4
 Someone else’s house/apartment 207 10
 Rooming/board/halfway house 29 1
 Shelter/welfare hotel 17 1




  Bronx, NY 307 15
  Brooklyn, NY 298 14
  Washington, DC 220 11
  Chicago, IL 262 13
  San Francisco, CA 276 13
 Southern 731 35
  Chapel Hill, NC 191 9
  Atlanta, GA 234 11
  Miami, FL 96 5
    Birmingham, AL  98 5
  Jackson, MS 112 5
Drug use in the past 6 months
 Both injection & non-injection drug use 13 1
 Injection drug use only 2 0
 Non-injection drug use only 502 24
 No reported drug use 1516 72
 Missing 61 3
(> 20–40% versus ≤ 20% PR, 1.27; CI, 0.94–1.71) and 
adjusted (> 20–40% versus ≤ 20% aPR, 1.12; CI, 0.85–1.48) 
analyses [Table 4].
Hypertension
We did not observe a difference in the prevalence of hyper-
tension with increasing neighborhood poverty in either 
HIV-seropositive or -seronegative women (Supplemental 
Table 2).
The prevalence of uncontrolled hypertension did not dif-
fer with increasing neighborhood poverty among HIV-sero-
positive women with self-reported hypertension (> 20–40% 
versus ≤ 20% aPR, 0.94; 95% CI 0.71–1.26; > 40–100% ver-
sus ≤ 20% aPR, 1.08; 95% CI 0.77–1.52). Among HIV-seron-
egative hypertensive women, uncontrolled hypertension was 
similar across all levels of neighborhood poverty (> 20–40% 
versus ≤ 20% aPR, 1.06; 95% CI 0.76–1.48; > 40–100% ver-
sus ≤ 20% aPR, 1.09; 95% CI 0.76–1.58) [Table 4].
Diabetes
The prevalence of diabetes was not associated with neigh-
borhood poverty among either HIV-seropositive or HIV-
seronegative women (Supplemental Table 2).
IQR interquartile range, ADAP AIDS drug assistance program, ART antiretroviral therapy
a Census tract-level data were obtained from the American Community Survey (2010–2014) [38]











 Privately insured 397 19
 Publicly insured 1318 63
 Insured, unknown type 3 0
 Missing 91 4








 ≤ $12,000 1024 49
 $12,001–$30,000 580 28






Proportion of census tract population below federal poverty  linea
 ≤ 20% 735 35
 20–40% 929 44
> 40–100% 430 21
We did not observe an association between the preva-
lence of uncontrolled diabetes and increasing neighbor-
hood poverty among HIV-seropositive women (> 20–40% 
versus ≤ 20% aPR, 0.85; 95% CI 0.59–1.22; > 40–100% 
versus ≤ 20% aPR, 1.08; 95% CI 0.69–1.69) [Table 4].
In HIV-seronegative women with diabetes, neighbor-
hood poverty was associated with uncontrolled diabetes, 
with a threshold effect in census tracts with > 20% poverty 
(> 20–40% versus ≤ 20% aPR, 1.75; 95% CI 1.02–2.98); 
effects were weaker and less precise among participants 
living in areas of extreme poverty (> 40–100% ver-
sus ≤ 20% aPR, 1.33; 95% CI 0.72–2.45) [Table 4].
Adjusting neighborhood poverty level cut-points in sen-
sitivity analyses did not substantially change the directions 
or magnitudes of observed point estimates for control of 
HIV, hypertension, or diabetes in either HIV-seropositive 
or HIV-seronegative women (data not shown).
Discussion
In this low-income population of predominantly African 
American women, over half of study participants resided 
in neighborhoods where more than 20% of residents lived 
 
Table 2  Control of HIV 
infection, diabetes, and 
hypertension among women 
whose addresses were 
geocoded, Women’s Interagency 
HIV Study, 2015
ART antiretroviral therapy
a Control for HIV = viral load ≤ 200 copies/mL; Control for diabetes = HgbA1c ≤ 7.0%; Control for hyper-
tension = systolic blood pressure ≤ 140 and diastolic blood pressure ≤ 90
b Outcome for HIV control is HIV viral load; outcome for hypertension control is blood pressure; outcome 
for diabetes control is HgbA1c













N % N % N % N % N % N %
Total 1463 1271 848 280 340 138
Controlled at index  visita 1160 79 1092 86 601 71 161 58 202 59 70 51
Uncontrolled at index visit 233 16 120 9 201 24 103 37 124 37 55 40
Missing outcome  databat index visit 70 5 59 5 46 5 16 6 14 4 13 9
Table 3  Median proportion 
of people living below the 
poverty line in census tracts 
and counties where participants 
reside, Women’s Interagency 
HIV Study, 2015
IQR interquartile range
a Census tract- and county-level data were obtained from the American Community Survey (2010–2014) 
[38]
Census  tracta Countya
Median IQR Range Median IQR Range
Proportion < poverty line 26 16–37 1–73 18 15–23 4–48
Proportion < poverty line by neighborhood poverty category
 ≤ 20% 12 8–17 1–20 17 13–18 4–20
 > 20–40% 29 25–34 20–40 23 23–31 20–38
 > 40–100% 47 43–50 40–73 48 48–48 48–48
Proportion of respondent’s own race < poverty line
 All respondents 27 41–49 26–73 24 15–23 4–48
 If respondent African American 30 19–42 0–91 27 23–30 8–54
 If respondent White 17 9–27 0–100 11 10–18 3–24
 If respondent other race 23 11–39 0–100 21 14–29 8–37
Proportion < poverty line by reported annual household income
 ≤ $12,000 29 20–40 2–73 18 17–23 6–48
 $12,001–$30,000 26 16–37 1–71 18 15–23 5–37



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































below the federal poverty line. Increased prevalence of 
uncontrolled viremia among HIV-seropositive women was 
associated with extremely high levels, but not moderately 
high levels, of neighborhood-level poverty. Among HIV-
seropositive women, we observed no associations between 
neighborhood poverty and uncontrolled hypertension or 
diabetes. Worse control of diabetes, but not hypertension, 
was associated with living in high-poverty neighborhoods 
in HIV-seronegative women, although this relationship was 
attenuated and imprecise, due to the small number of par-
ticipants who lived in neighborhoods of extreme poverty.
Previous research revealed associations between HIV 
infection prevalence and both personal poverty and residence 
in a high-poverty area [46, 47]. In British Columbia, with 
universal healthcare, residence in a high-poverty area was 
associated with increased mortality among people with HIV 
[18]. In New York City, residents of high poverty neighbor-
hoods were less likely to maintain viral suppression than 
residents of lower poverty neighborhoods [26]. Our study, 
unlike this prior analysis, controlled for personal income and 
other individual-level indicators of socioeconomic status. 
We confirmed the relationship between viremia and extreme 
neighborhood level poverty. As expected, this relationship 
was largely driven by the smaller proportion of women liv-
ing in areas of extreme poverty receiving ART compared to 
those who lived in areas with less poverty. In high-poverty 
areas, low ART receipt may be due to structural factors 
that inhibit access to adequate HIV care, such as a limited 
number of HIV providers and pharmacies, or administrative 
burdens related to providing HIV services at clinics serv-
ing low-income clients [48]. Over half of the women with 
detectable viremia in this study were receiving ART. The 
stressors of living in areas of extreme poverty (e.g., elevated 
crime rates, homelessness, food insecurity) may interfere 
with the ability of residents to adhere adequately to ART 
and subsequently control HIV.
Although it is possible that the lack of observed associa-
tions between neighborhood-level poverty and either hyper-
tension or diabetes control among HIV-seropositive women 
is real, we believe these results may be due to other reasons. 
First, study participants generally lived in neighborhoods 
of concentrated poverty and were themselves overwhelm-
ingly poor, with nearly half of women reporting an annual 
household income ≤ $12,000. Only 13% of women lived in 
areas with low (< 10%) levels of poverty, and one-third of 
these women were poor themselves. This restricted range of 
individual income and neighborhood poverty is a testimony 
to the difficult socioeconomic contexts in which women with 
HIV live and may have limited our ability to observe asso-
ciations between neighborhood poverty and hypertension 
and diabetes control. The results of this analysis reflect a 
complex interaction between individual- and neighborhood-
level factors related to poverty and health. Both individual 
income and neighborhood poverty likely affect a person’s 
ability to access health-care and control disease [27, 28]. 
Furthermore, unadjusted prevalence estimates for diabe-
tes control among HIV-seropositive women living in high 
poverty areas were approximately equal to estimates among 
HIV-seronegative women living in low poverty areas, pos-
sibly because HIV-seropositive women often receive care 
for comorbid conditions during HIV care visits and have 
improved access to free or reduced price treatment to con-
trol diabetes and hypertension via the ADAP [49, 50]. Since 
HIV-seronegative women may not access healthcare as 
regularly as HIV-seropositive women, they may be more 
susceptible to adverse effects from living in poor neighbor-
hoods. We did not observe similar results for hypertension 
control, possibly because hypertension may be more likely 
to remain undiagnosed than diabetes. Because our classifi-
cation of hypertension was mostly based on self-report, if 
women living in higher poverty neighborhoods were more 
likely to have undiagnosed hypertension, there may be 
greater differences across levels of neighborhood poverty 
than we observed in this analysis, which may have led to 
underestimates of the associations between neighborhood-
level poverty and uncontrolled hypertension.
Women participating in the WIHS may fundamentally 
differ from non-participants living in similar neighborhoods. 
HIV-seropositive participants in the WIHS are racially and 
ethnically representative of women with HIV infection in 
the US, and HIV-seronegative enrollees are well-matched 
to HIV-seropositive women with respect to demographic 
and HIV-risk characteristics [30–32]. However, compared 
to national estimates in women, a higher proportion of HIV-
seropositive WIHS participants had a suppressed VL (55% 
among women nationally versus 79% among WIHS partici-
pants), controlled hypertension (53% among women nation-
ally versus 71% among WIHS participants), and controlled 
diabetes (54% among women nationally versus 58% among 
WIHS participants) [7, 9, 10]. It is possible that WIHS 
women residing in poor neighborhoods may be better able 
to access medical assistance and treatment for their HIV 
infection, diabetes, and hypertension than non-participants 
who live in similar neighborhoods [51]. We were unable 
to include homeless women in this analysis because these 
women did not have an address to geocode. If homeless 
women have worse outcomes and cluster in high poverty 
neighborhoods, their exclusion could have underestimated 
our observed associations.
Racial differences in mortality among people with HIV 
often persist, even when access to care appears equal [52, 
53]. Because African Americans are more likely to live 
in high poverty areas, neighborhood context may at least 
partially explain this racial disparity in mortality and result 
from the higher prevalence of people with uncontrolled HIV 
infection in these neighborhoods.
Defining a person’s neighborhood poses methodologic 
challenges. In this analysis, we used census tract delinea-
tions to define each woman’s neighborhood, which corre-
spond reasonably well to the perceptions of neighborhood 
boundaries of most Americans living in urban areas [39] and 
have been previously shown to be valid geographical units 
of analysis to assess health inequities [37]. Although it is 
possible for residents of the same census tract to experience 
different levels of contextual poverty, census tracts typically 
include populations with similar social characteristics [54] 
and are the smallest geographic unit with an estimate for 
the proportion of individuals who live below the poverty 
level [55]. In this analysis, poverty estimates for WIHS par-
ticipants may have been misclassified due to a discrepancy 
in dates; neighborhood poverty estimates were based on a 
sample of responses in the ACS over a 5-year period end-
ing in 2014, but the index visit and all corresponding health 
outcomes were obtained in 2015. However, it is unlikely 
that poverty levels decreased substantially in neighborhoods 
where most WIHS participants resided during this timeframe 
[56]. In addition, both the neighborhood poverty indicator 
and the WIHS individual income variable may not capture 
wealth or financial support networks accurately. Urban high 
poverty neighborhoods may differ from suburban and rural 
high poverty areas in terms of availability of and access to 
resources, including healthcare services [56]. Although both 
the original and Southern WIHS sites are located in mostly 
urban areas, the patient population that each site draws from 
extends beyond urban centers into more rural areas. Fur-
thermore, WIHS participants living with HIV mirror the 
HIV epidemic among US women in terms of race, ethnic-
ity, and socioeconomic status, [51] providing support for 
the generalizability of our results. Finally, the small number 
of HIV-seronegative women with uncontrolled diabetes and 
hypertension also limited this analysis. However, dichoto-
mous comparisons between women living in impoverished 
neighborhoods (> 20–100% poverty) and those living in 
non-impoverished neighborhoods (≤ 20% poverty) suggest 
associations, though modest, between neighborhood-level 
poverty and both uncontrolled diabetes and uncontrolled 
hypertension, even when sample size is limited.
This study suggests that neighborhood-level poverty may 
interfere with diabetes control as well as access or adher-
ence to ART among women living in the US. The lack of 
observed associations between neighborhood poverty and 
control of some diseases, such as hypertension, may be 
true null associations, or instead due to the fact that WIHS 
participants receive many services that other women (both 
HIV-seropositive and HIV-seronegative) living in areas of 
poverty cannot access. Regardless, the results of this study 
provide an initial insight into the pathways between socio-
economic context and adverse health outcomes. Future 
research incorporating duration of residence in high poverty 
neighborhoods as well as the specific characteristics of high 
poverty neighborhoods that interfere with the ability of resi-
dents to control chronic conditions such as HIV, hyperten-
sion, and diabetes is needed to build upon this understanding 
and develop effective policies at the state and local levels to 
address these disparities. Interventions that assist women 
living in poor neighborhoods to navigate the healthcare 
system could improve their ability to access resources that 
effectively control existing health conditions and decrease 
community-wide inequalities.
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